A carregar...
β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology
Alzheimer’s disease (AD) is a progressive, late-onset dementia with no effective treatment available. Recent studies suggest that AD pathology is driven by age-related changes in metabolism. Alterations in metabolism, such as placing patients on a ketogenic diet, can alter cognition by an unknown me...
Na minha lista:
| Publicado no: | J Neuroinflammation |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7507727/ https://ncbi.nlm.nih.gov/pubmed/32958021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-020-01948-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|